Accelerating oncology drug discovery with HUB Organoids

February 17, 2022

Accelerating oncology drug discovery with HUB Organoids

Oncology drug development is especially risky with only 5% of new compounds reaching market approval. The lack of patient-relevant, early-stage preclinical models...

read more

X

Have any questions?

contact us